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Abstract
Motivation: Multiple biological clocks govern a healthy pregnancy. These biological mechanisms
produce immunologic, metabolomic, proteomic, genomic and microbiomic adaptations during the
course of pregnancy. Modeling the chronology of these adaptations during full-term pregnancy
provides the frameworks for future studies examining deviations implicated in pregnancy-related
pathologies including preterm birth and preeclampsia.
Results: We performed a multiomics analysis of 51 samples from 17 pregnant women, delivering
at term. The datasets included measurements from the immunome, transcriptome, microbiome,
proteome and metabolome of samples obtained simultaneously from the same patients.
Multivariate predictive modeling using the Elastic Net (EN) algorithm was used to measure the abil-
ity of each dataset to predict gestational age. Using stacked generalization, these datasets were
combined into a single model. This model not only significantly increased predictive power by
combining all datasets, but also revealed novel interactions between different biological modal-
ities. Future work includes expansion of the cohort to preterm-enriched populations and in vivo
analysis of immune-modulating interventions based on the mechanisms identified.
Availability and implementation: Datasets and scripts for reproduction of results are available
through: https://nalab.stanford.edu/multiomics-pregnancy/.
Contact: naghaeep@stanford.edu
Supplementary information: Supplementary data are available at Bioinformatics online.
1 Introduction
Physiological changes during pregnancy are highly dynamic and in-
volve coordinated changes among multiple interconnected molecu-
lar and cellular systems from the fetus, the fetal-membrane and the
mother (Diemert and Arck, 2018; Menon et al., 2016). The simul-
taneous interrogation of these systems can reveal otherwise unrecog-
nized crosstalk. Understanding such crosstalk can inform several
lines of investigation. From a biological perspective, it can point to
important disease mechanisms such as immune programming by the
microbiome, or specific interactions between proteins and cellular
elements (Aghaeepour et al., 2017; Dethlefsen et al., 2007). From a
diagnostic perspective, it can reveal biomarkers from several bio-
logical domains that provide higher predictive power if combined.
Alternatively, it can point to alternative biomarkers in an accessible
biological compartment, which can replace biomarkers that are dif-
ficult to obtain or expensive to measure.
Recent technological advances in science provide novel opportu-
nities to unravel the complex biology of pregnancy. A particularly
pressing issue is to identify the biological pathways and the converg-
ing pathological processes that lead to preterm birth (Lackritz et al.,
2013). Preterm birth is the major cause of neonatal death, and the
second leading cause of mortality in children under the age of
5 years (Liu et al., 2012). An ongoing cohort study by the March of
Dimes Prematurity Research Center at Stanford University exploits
recent technological advances to examine an array of biological,
demographic, clinical and environmental factors associated with
normal and pathological pregnancies (Stevenson et al., 2013; Shaw
et al., 2018; Wise et al., 2017). From a biological perspective, this
effort has so far produced two major lines of evidence. One line
sheds light onto precisely tuned chronological changes that occur
during normal pregnancy. For example, a highly multiplexed cell-
based assay in whole blood revealed an ‘immunological clock’ of
human pregnancy that predicts gestational age at the time of sam-
pling (Aghaeepour et al., 2017). Similar results were reported in a
longitudinal analysis of cell-free, maternal RNA (Pan et al., 2017)
and plasma proteins (Aghaeepour et al., 2018). The primary object-
ive of using gestational age as the clinical outcome in these studies is
to extract molecular features that best capture normal chronological
changes over the course of term pregnancy. Such knowledge will
elucidate molecular deviations that are associated with pregnancy-
related pathologies. The second line of this work points to important
pathophysiological derangements. For example, dense longitudinal
sampling of the vaginal microbiome revealed community compos-
ition profiles associated with preterm birth that were validated in an
independent cohort (Callahan et al., 2017; DiGiulio et al., 2015).
However, the important work of bringing these data modalities to-
gether has remained unexplored.
From a bioinformatics point of view, current multiomics efforts
belong to two categories generally known as multi-staged and meta-
dimensional (Ritchie et al., 2015; Rohart et al., 2017). In multi-
staged analyses, measurements of the same biological factors (e.g.
genes) are integrated at various biological levels and using different
technological platforms (e.g. DNA and RNA sequencing, epigenetic
analysis and proteomics assays—notable examples include
(Emilsson et al., 2008; Maynard et al., 2008; Schadt et al., 2005;
Shabalin, 2012; Shen et al., 2009)). However, recent biological stud-
ies extend well beyond just measurements of the same gene/protein
and include various assays that cannot be mapped to a single gene.
These include single cell analysis (Aghaeepour et al., 2017), imaging
(Woodward et al., 2006), profile of metabolic profiling (Piening
et al., 2018), actigraphy using wearable sensors (Halilaj et al., 2018)
and clinical phenotypes (Ferrero et al., 2016). Meta-dimensional
multiomics approaches are now emerging that aim to combine het-
erogeneous datasets to identify key factors at various biological
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levels, their interactions with each other, and with clinical outcomes.
Some studies achieve this by simply merging all available datasets
into a single matrix for joint modeling (Fridley et al., 2012;
Holzinger et al., 2014; Mankoo et al., 2011). These approaches are
often susceptible to biases introduced by the differential sizes, modu-
larities, scalings and batch effects of the included datasets. Various
kernel (e.g. Borgwardt et al., 2005) and graph (e.g. Kim et al., 2012)
transformations as well as latent space projections (Singh et al.,
2016) have been proposed to address these biases. In settings where
analysis is performed against an external factor, an alternative is to
use mixture-of-experts methods to combine the results of independ-
ent models produced using each dataset through various algorithms
ranging from voting (e.g. Aghaeepour and Hoos, 2013) to integra-
tion of posterior Bayesian probabilities (Akavia et al., 2010; Zhu
et al., 2008, 2012).
The main objective of this study was to test multiple strategies
for integrating transcriptomic, immunological, microbiomic, metab-
olomic and proteomic datasets into different statistical models pre-
dicting gestational age in term pregnancy and identify the most
accurate strategy. A final objective was to interrogate the derived
model for novel and testable biological hypothesis.
2 Materials and methods
2.1 Study design
Pregnant women presenting to the obstetrics clinics of the Lucile
Packard Children’s Hospital at Stanford University for prenatal care
were invited to participate in a cohort study to prospectively exam-
ine environmental and biological factors associated with normal and
pathological pregnancies. Women were eligible if they were at least
18 years of age and in their first trimester of a singleton pregnancy.
In 17 women, three samples were collected during pregnancy and a
fourth one after deliver. The time points were chosen such that a
peripheral blood sample (CyTOF analysis), a plasma sample (prote-
omic, cell-free transcriptomics, metabolomics analyses), a serum
sample (luminex analyses) and a series of culture swabs (microbiome
analysis) were simultaneously collected from each woman during
the first (7–14 weeks), second (15–20 weeks) and third (24–
32 weeks) trimester of pregnancy and 6-week postpartum. Repeated
sampling during pregnancy allowed assessing important biological
adaptations occurring continuously from the early phases of fetal
development (first trimester) to the late phases of gestation (third tri-
mester). The sample collected 6-week postpartum allowed for the
assessment of the biological variables after the delivery of the fetus,
a surrogate for the non-pregnant state which is not accessible in a
prospective study of pregnant women.
2.2 Gestational age estimation
Gestational age was determined by best obstetrical estimate as rec-
ommended by the American College of Obstetricians and
Gynecologists (Hershey, 2014).
2.3 Biological assays
Plasma and serum samples were assayed using the Luminex plat-
form for cytokine levels. In addition, plasma samples were used for
proteomics analysis, LC-MS metabolomics analysis, and cell-free
transcriptomic analysis. Whole blood samples were analyzed using
mass cytometry for single-cell characterization of the immune sys-
tem. Finally, vaginal swabs, stool, saliva and tooth/gum samples
were used for microbiomic profiling. See Supplementary Material
for more detailed description of the assays. All timepoints of a given
patient were analyzed simultaneously by all omics platforms to min-
imize systematic technical confounders (Supplementary Fig. S4).
2.4 Multivariate modeling
For a matrix X of all features from a given dataset, and a vector of
estimated gestational ages at the time of each sampling, Y, the EN
algorithm calculates coefficients b to minimize the error term
LðbÞ ¼ jjYXbjj2. An L1 regularization (Tibshirani, 1996) was
used to increase model sparsity (which facilitates biological inter-
pretation and validation). However, this approach is not ideal for
the analysis of the highly interrelated biological datasets, because it
only selects representatives of communities of highly correlated fea-
tures. As a result, features correlated to these selected representatives
are disregarded, despite the fact that they could be biologically rele-
vant. This limitation is addressed by using an additional L2 regular-
ization penalty: Lða; k; bÞ ¼ jjYXbjj2 þ k½ð1  aÞjjbjj2 þ ajjbjj1,
where jjbjj2 ¼ b>b and jjbjj1 ¼
Pn
i¼1 jbij. The subset selecting factor
k controls the sparsity of the model and the smoothing factor a con-
trols the smoothing of selection from correlated variables (Zou and
Hastie, 2005).
2.5 Stack generalization
In the computer science literature, stacked generalization refers to
the practice of combining several weak predictors for increased pre-
dictive power (Breiman, 1996; Sharkey, 1996; Wolpert, 1992). In
life sciences, this often translates to analysis of a single dataset using
multiple algorithms and then combining the results in a final multi-
variate modeling step (Ge and Wong, 2008; He et al., 2013;
Larranaga et al., 2006; Yang et al., 2010; Wang et al., 2006). Here
we expand this concept to multiomics analysis where a single multi-
variate analysis algorithm (EN) is used on a cohort of patients, and
the variable factor is the biological assays used for developing the
datasets. First, an EN model is constructed on each dataset from the
same subjects. Then, all estimations of gestational age at time of
sampling are used as features for a final EN model. This, essentially,
is a weighted average of the individual models where the weights are
the coefficients of the EN model.
2.6 Cross-validation
An underlying assumption of the EN algorithm is statistical inde-
pendence between all observations. In this analysis, while the sub-
jects are independent, the samples collected from various trimesters
of the same subject are not. To account for this, we designed a
leave-one-subject-out cross-validation strategy. In this setting, a
model is trained on all available samples except for the three trimes-
ters of a given subject. The model is then tested on all samples of the
subject that it was blinded to. This process is repeated for all sub-
jects until a blinded prediction has been produced for all samples.
Final results are reported using these blinded predictions. This
ensures complete independence from any intra-subject correlations.
A two-layer cross-validation strategy was implemented for sim-
ultaneous free-parameter optimization and analysis of the generaliz-
ability of the results (Fig. 2A). The inner layer selects the best values
of a and k (see Supplementary Fig. S1). The outer layer ensures that
performance is reported on subjects that the models were blinded to
during training.
A similar strategy was used for the stacked generalization step.
Cross-validation folds where synchronized between the individual
models from each dataset and the integrated model to leave out the
same set of data points at all levels of the analysis. Importantly, this
guarantees that not only the stacked generalization model, but also
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its input features (i.e. the final predictions from each dataset) were
blinded to the same subject during cross-validation.
2.7 Empirical evaluation
The procedure described above was empirically compared against a
number of standard multivariate algorithms. The same algorithms
were used for the individual datasets as well stacked generalization
(Fig. 5). The algorithms included Random Forest (Breiman, 2001),
Gaussian Process (Williams and Barber, 1998), Support Vector
Regression (Chang and Lin, 2011; Hsu and Lin, 2002) and XGboost
(Chen and Guestrin, 2016). The algorithms were compared using
the default implementations provided in the following packages:
(Chen and He, 2015; Karatzoglou et al., 2004; Liaw and Wiener,
2002). All algorithms were evaluated using the same two-layer
leave-one-patient-out CV strategy. The cross-validated parameter
space for Gaussian process and Support Vector Regression included
all available kernels [as described in (Karatzoglou et al., (2004)] and
initial noise variance between 0.001 and 10 000. EN predominantly
outperforms the other methods on most datasets, followed by sup-
port vector regression. XGboost outperforms the other algorithms
on the microbiome dataset.
2.8 Model reduction
A bootstrapping procedure was used to reduce the number of fea-
tures used in each model. As described in Aghaeepour et al. (2017),
one hundred bootstrap iterations were performed on each dataset
where 57 samples were drawn randomly and with replacement.
Piece-wise regression between the number of features (calculated by
applying a range of thresholds to the mean coefficient of each meas-
urement across all bootstrap iterations) and the final results of the
models were used to select the number of features for each modality
(Oosterbaan, 1994).
2.9 Correlation network
The features from the reduced models were visualized using a graph
structure. Each feature was represented by a node. The correlation
structure between the features was extracted using a Minimum
Spanning Tree (MST) where the width of the edges were proportion-
al to the spearman P-value of the correlation between the two nodes,
on a log 10 scale. The graph was visualized using the Fruchterman-
Reingolds layout (Fruchterman and Reingold, 1991).
2.10 P-value adjustment
All P-values were adjusted using Bonferroni’s method
(adjusted-P-value ¼ minf1; raw-P-value ng), where n is the num-
ber of features (Dunn, 1961).
2.11 Missing value interpolation
Missing values for all datasets were interpolated using a non-
parametric multivariate model based on random forests. A model
was trained for each feature of each dataset, and was subsequently
used to estimate the missing values as described in Stekhoven and
Bu¨hlmann (2012).
3 Results
3.1 Modularity and size
Samples from 17 women for a total of 51 timepoints throughout
pregnancy and 6 weeks postparturm were collected. Samples were
analyzed for seven biological modalities: cell-free transcriptomics,
antibody-based cytokine measurements in plasma and serum, micro-
biomic analyses (of vaginal swabs, stool, saliva and tooth/gum),
mass cytometric analyses of whole blood, untargeted metabolomics
and targeted proteomics analysis of plasma. These datasets pro-
duced different levels of modularity (as measured by the number of
principal components needed to account for 90% variance of each
dataset—Fig. 1C). The modularity of the datasets (Fig. 1C) was not
correlated with the number of measurements available (Fig. 1B).
3.2 Per-dataset analysis
An Elastic Net (EN) model was developed to predict the gestational
age of pregnancy of each subject at each visit. A two layer Cross-
Validation (CV) procedure was used to both optimize the free
parameters of the EN model (see Supplementary Fig. S1) and to en-
sure that predictions were made on samples that were not used for
training model coefficients (see Fig. 2A and Section 2).
Supplementary Figure S2 visualizes the predictions on the test sam-
ples for each modality versus the clinical estimations of gestational
age. P-values of correlation with gestational age at time of sampling
for the training and testing procedures are presented in Figure 2B
and C, respectively. Plasma proteomics analysis using the
SomaLogic platform produced the strongest predictive power
(Fig. 2B and Supplementary Fig. S6). Results remained generally
consistent between training and test sets (Fig. 2C). The datasets with
a higher degree of independence between features (Fig. 1C) had a
higher predictive power regardless of their size.
Due to the absence of true pre-pregnancy samples, we applied
these models to postpartum samples collected 6 weeks postpartum
as a surrogate for a non-pregnant state. At that time, some models
(e.g. the immunologic and metabolomic models) recovered towards
a state similar to a non-pregnant state, while others more closely
reflected an early pregnant state or remain stable after delivery. This
finding indicates that not all biological factors involved in pregnancy
recover at a similar rates (Fig. 2D).
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Fig. 1. (A) Overview of the study design. A total of 357 samples from 51 visits
by 17 women were collected during three trimesters of pregnancy, as well as
an additional 17 samples 6 weeks after delivery. Seven datasets were pro-
duced for each visit by each subject. (B) Data from each time point of each
subject were analyzed using seven high-throughput assays, which produced
different number of measurements. (C) The seven datasets had a range of
correlations among the measured features. The internal correlation between
features from each dataset was quantified using the number of Principle
Components (PCs) needed to capture 90% variance (datasets in which most
features are highly correlated would need fewer principal components)
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3.3 Stacked generalization
A stacked generalization strategy was used to combine the predictive
powers of the different omics datasets as described in Wolpert
(1992). As illustrated in Figure 3A, an EN model was first trained
on each dataset. Then, the estimations of gestational age produced
by the seven independent models were merged using an additional
EN model. Cross-validation was synchronized across all layers to
ensure predictions were made on samples that had not been used for
optimizing model coefficients. The free parameters of the models, as
calculated using the inner CV procedure (see Section 2), are visual-
ized in Supplementary Figure S1.
Ablation analysis, a procedure for investigating the path of data-
set weights by iteratively retraining the stacked generalization
model, was used to measure the relative contribution of each dataset
to the final predictions (Fawcett and Hoos, 2016). This procedure
was performed by iteratively removing the most important dataset
from the mix (Fig. 4A). Importantly, for each iteration, the algo-
rithm was able to recalculate new weights for the remaining datasets
to partially compensate for any lost information. For example, after
removal of the proteomic and metabolomic datasets, the algorithm
significantly increased the weight of the predictions based on the im-
mune system to compensate for the two removed datasets. Similar
analysis in reverse order (Fig. 4B) revealed a minimal decrease in the
predictive power when the most important dataset was preserved.
To enable biological exploration, the top hits from each model
were extracted using a bootstrapping strategy for sensitivity analysis
(see Section 2 for details) and visualized using a minimum spanning
tree of Spearman correlations between the selected features on a
Fruchterman-Reingold layout (Fruchterman and Reingold, 1991), in
Figure 3B and C, respectively. This resulted in a set of 226 interre-
lated features (Supplementary Table S1), revealing statistically ro-
bust interactions within and between each omics dataset. A
Minimum Spanning Tree (MST) representation organized these
interactions into a branched structure in which the distance between
two features is proportional to the strength of the correlation be-
tween them. Metabolomics, transcriptomics and proteomics features
primarily segregated into three clusters (Fig. 3C). Cell-based features
from the immune system were distributed across the MST graph,
forming a link between other omics datasets rather than being con-
fined to a single cluster. The MST graph highlighted the connectivity
between biological processes measured in the plasma (metabolomic,
transcriptomic and proteomic measurements) or local compartments
(microbiomic data) and cell-specific immune responses measured in
the peripheral blood compartment.
3.4 Biological hypothesis generation
Several biologically plausible and hypothesis generating correlations
between omics datasets emerged. Here, we highlight three of these
data-driven hypotheses. In one instance, we illustrate how the inte-
grative dataset can inform additional experiments that allow further
exploration of the nature of observed interaction between different
omics features.
With respect to the microbiomic data, a strong correlation was
observed between changes in the composition of Neisseria bacterial
species localized in the oral cavity as well as Bacteroides species in
the gut and TCRcdþ T cells. This finding is consistent with the
unique role of TCRcdþ T cells in mucosal immunity, particularly in
the control of oral pathogens (Chien et al., 2014; Moutsopoulos and
Konkel, 2018; Wu et al., 2014). Given increasing epidemiological
evidence linking oral cavity dysbiosis and pregnancy-related compli-
cations, such as preterm labor and preeclampsia (Bassani et al.,
2007; Boggess et al., 2003; Bosnjak et al., 2006; Hajishengallis,
2015; Herrera et al., 2007; Nabet et al., 2010), our results raise the
hypothesis that the correlation between the changes in oral bacterial
species and TCRcdþ T cell frequencies may be disrupted in patho-
logical pregnancies, such as preterm pregnancies.
With respect to the metabolomics dataset, the model revealed
strong correlations between the plasma factor pregnanolone
sulfate and the NF-jB signaling in myeloid dendritic cells (mDCs)
and regulatory T cells (Tregs). Pregnanolone sulfate, or 3a; 5b-
tetrahydroprogesterone(3a; 5b-THP), is an endogenous steroid bio-
synthesized from progesterone. Modulation of immune cell function
by progesterone and its derivative is well established (Druckmann
and Druckmann, 2005). However, their roles in regulating the func-
tion of specific immune cell subsets during pregnancy are not fully
Fig. 2. (A) Overview of the two-layer CV procedure. On the outer layer, a
modified leave-one-out procedure is used in which all samples from the
same subject (as opposed to just one sample) are left out as a blinded data-
set. Within each fold, a second CV procedure is performed to optimize the
free parameters of the EN model. Test samples for the inner and outer layers
are visualized in red and green, respectively. The final training prediction is
the median of predictions from all models that included that patient during
their training (bottom), and the final blinded test set prediction comes from
the only model that was blinded to it (top). See Section 2 for details. (B) and
(C) The Spearman correlation P-values of the (B) training set and (C) test set
results of the CV procedure for each dataset. (D) The models for each dataset
applied to all samples including the postpartum visit 6 weeks after delivery.
The average trend for each platform is visualized using kernel density estima-
tion for smoothing. The delivery range is highlighted in gray. Some models
quickly recover towards a non-pregnant status (below the first trimester)
while others remain stable after delivery
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understood. The results thus generated a novel hypothesis that preg-
nanolone sulfate may regulate important aspects of mDC and Treg
functions during pregnancy.
With respect to the proteomic dataset, a three-way interaction
between the transcriptomic, proteomic and cytomic datasets was
particularly interesting, as it highlighted a novel connection between
previously reported models of molecular clocks of pregnancy. This
interaction contained the Chorionic Somatomammotropin
Hormone-1 (CSH-1), represented at the transcript (cell-free RNA
dataset) and protein (Somalogic dataset) levels, and the endogenous
activity of the transcription factor STAT5 measured at the single-
cell level in CD4þ and CD8þ T cell subsets. CSH-1 is known to
bind to the prolactin receptor (Walsh and Kossiakoff, 2006), which
signals through the JAK2/STAT5 signaling pathway (Gouilleux
et al., 1994). As such, results from the integrative analysis informs a
novel hypothesis that CSH-1 may directly activate the JAK2/STAT5
signaling pathway in CD4þ and CD8þ T cell subsets during
pregnancy.
The strong correlation observed between CSH-1 RNA and pro-
tein levels, and STAT5 activity in T cells (R¼0.59, P ¼
4:40  1006) prompted further examination of this hypothesis in
an in vitro model to determine whether CSH-1 can directly activate
the JAK2/STAT5 signaling pathway in T cells. However, incubation
of whole blood samples from non-pregnant or pregnant
(Supplementary Fig. S3) women with CSH-1 did not induce the
phosphorylation of STAT5 in CD4þ or CD8þ T cell subsets. On
further inspection of the proteomic dataset, CSH-1 was found to be-
long to a community of tightly correlated plasma factors known to
regulate the JAK/STAT signaling pathway. This community
included the inflammatory cytokine Interleukin-2. Supplementary
Figure S3 shows that, in contrast to CSH-1 or prolactin, incubation
of whole blood samples with IL-2 induced a robust STAT5 phos-
phorylation signal in all major T cell subsets. These results suggested
that in the context of pregnancy, the progressive increase in intracel-
lular STAT5 activity in T cell subsets is likely driven by changes in
IL-2 rather than CSH-1.
4 Discussion
We have described an analysis of seven high-throughput biological
modalities during term pregnancy. An agnostic machine learning ap-
proach was used to evaluate the predictive power of each dataset for
estimation of gestational age using biological signals. An additional
machine learning layer was used to combine these estimations to fur-
ther increase predictive power. Importantly, these datasets differed
in both size and modularity. By taking this two layer approach, we
prevented higher-dimensional datasets from overwhelming the final
model. This both increased predictive power and facilitated bio-
logical interpretation.
Fig. 3. (A) Stacked generalization analysis. The size of the boxes is proportional to the log 10 of the number of measurements in each dataset. The thickness of
the arrow is proportional to the  log 10 of P-value of a correlation test for gestational age; (B) The number of model components (x-axis) versus the P-value of
the Spearman correlation between each model and gestational age (y-axis). Lines represent the piece-wise regression fit for calculation of the number of features.
(C) Visualization of the most predictive features in a correlation network. The size of each node is proportional to the univariate correlation between that feature
and gestational age. Color represents the corresponding dataset
A B
Fig. 4. Ablation analysis to measure the collective predictive power of the
model after removal of each dataset. At each iteration, the most (A) or least
(B) important datasets were removed from stacked generalization. Color is
proportional to the coefficients of the stacked generalization model. At each
iteration, the algorithm was able to readjust the coefficients. This demon-
strated that the algorithm could effectively use the remaining datasets to
compensate for the latest removals
-
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Fig. 5. Empirical evaluation of elastic-net, random forest, XGboost, Gaussian
Process and Support Vector Regression on each dataset, and the combin-
ation of all datasets. The hyper parameters of each method were tuned by the
same two-layer leave-one-patient-out CV procedure for the prediction of ges-
tational age on the test set. EN predominantly outperformed the other meth-
ods on most datasets, followed by support vector regression. XGboost
outperformed the other algorithms on the microbiome dataset
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Using this approach, we estimated the gestational age of the fetus
at the time of each sampling. The stacked generalization algorithm
produced models more accurate than models derived from any indi-
vidual dataset. Ablation analysis (Fawcett and Hoos, 2016) was
used to study the impact of each dataset on the final predictions.
Importantly, this analysis showed that by retraining the stacked gen-
eralization model, other datasets could partially compensate for the
removal of a given dataset. Using sensitivity analysis and piece-wise
regression and sequential feature-reduction, each model was reduced
to a limited number of required measurements. These were then
used for correlation analysis, visualization and biological interpret-
ation. These two complementary model reduction procedures lay
the foundation for objective analysis to strike a balance between
predictive-power and assay/sampling costs in resource-poor settings
(e.g. a more expensive assay which requires a larger sample size
from a complex biopsy may be replaceable by two cheaper and
more feasible assays).
The study provided an integrated biological model of maternal
changes during pregnancy, highlighting the interconnectivity of mul-
tiple biological systems. Notably, strong correlations between
metabolomic, proteomic, transcriptomic features and specific im-
mune cell signaling responses pointed at biologically plausible inter-
actions. For example, the model identified a strong relationship
between the steroid hormone pregnanolone sulfate and the signaling
behavior of mDCs and Tregs. mDCs and Tregs play a critical role in
feto-maternal tolerance and the maintenance of pregnancy
(Aluvihare et al., 2004; Erlebacher, 2013). Our data provide the
basis for a novel hypothesis that pregnanolone sulfate plays a role in
regulation of the function of these two cell types during pregnancy.
Alternatively, recent evidence indicating that T cells can produce
pregnenolone, the precursor of pregnanolone sulfate (Mahata et al.,
2014), suggests that immune cells may be a cellular source of preg-
nanolone sulfate production, providing another hypothesis for the
observed correlations.
The study also shows that the biological interpretation of
observed interactions between two model components benefits from
exploring the communities of features that strongly correlate with
these model components. As such, the integrative model revealed a
strong interaction between the protein factor CSH-1 and STAT5 ac-
tivity in CD4þ T cells. However, a community of protein factors
correlating with CSH-1 contained the cytokine IL-2, a canonical ac-
tivator of the JAK/STAT5 signaling pathway in CD4þ T cells
(Mahmud et al., 2013). Together with our in vitro data showing
that stimulation with IL-2, but not with CSH-1, results in STAT5
phosphorylation in CD4þ T cells, these findings suggest that the
interaction between CSH-1 and STAT5 activity in CD4þ T cells is
likely indirectly mediated by IL-2. For example, activation of the
PRL/CSH-1 receptor in cells other than T lymphocytes has been
shown to promote the transcription of IL-2 (Sun et al., 2004). CSH-
1 may thus be implicated in the paracrine regulation of T cell func-
tion through positive regulation of IL-2 gene expression in other im-
mune or non-immune cell types. When applied to postpartum
samples collected 6 weeks after delivery, these models demonstrated
that different biological modalities return to a non-pregnant state at
different rates, reflecting synchronized pacemakers (Diemert and
Arck, 2018). This finding motivates detailed biological analysis of
the role of the inter-pregnancy interval (Girsen et al., 2018) and his-
tory of preterm birth in adverse outcomes (Gaudillie`re et al., 2015).
Selecting the hyperparameters of an EN model is largely a bal-
ancing act between sparsity and accuracy. In complex biological
datasets, this is often confounded by the intrinsic characteristics of
data including size and modularity (Waldmann et al., 2013). To
address this, a two-step CV procedure was used in this analysis. The
inner layer enables optimization for the free-parameters of the EN
model using an exhaustive grid search (Supplementary Fig. S1). The
outer layer ensures the generalizability of the results to previously
unseen samples. To increase sample size, each sample extracted at a
trimester from a single subject was treated as an independent data
point. To ensure the models were not biased by the dependency be-
tween samples donated by the same subject, all three trimesters of a
given subject were excluded together in the same CV fold.
Therefore, reported results are based on models that had access to
no samples from a subject in the test-set. The samples used for test-
ing purposes in all CV steps were synchronized across all models.
Therefore, all test-set results (including those of the stacked general-
ization models) are reported only on samples that were blinded in
all previous analyses.
This study has several limitations that have inspired our future
plans. First, the number of subjects in this ‘proof-of-concept’ cohort
was small relative to the number of measurements. In addition, re-
cruitment from a single-care center limited the diversity of the data-
set. Despite this, we were able to capture the chronology of
biological changes during pregnancy. This correlation was not
driven by age, BMI, or parity (partial correlation test P>0.05).
However, given the racial disparities in pregnancy outcomes, repli-
cating this analysis in more diverse cohorts is crucial. The March of
Dimes Prematurity Center at Stanford University has already
engaged in several international collaborations to directly address
this. Similarly, the number of measurements was significantly larger
than the cohort size, which increased the possibility of false posi-
tives. In addition to carefully designed cross-validation, feature re-
duction and clustering (e.g. Bien and Tibshirani, 2011) can be used
to improve the predictive power of multivariate models in high-
dimensional settings and enable exploration of more interactions be-
tween different datasets. These various approaches should be tested
in an unbiased and collaborative setting (e.g. Aghaeepour et al.,
2016; Stolovitzky et al., 2007) as large multiomics datasets become
available. Finally, the current dataset included only one sample per
trimester, and these samples were treated as independent datapoints.
In the future, high-resolution sampling together with mixed effect
models (Gałecki and Burzykowski, 2013) will combine the informa-
tion content of different timepoints to produce increasingly more ac-
curate prediction of pregnancy related events using serial sampling
throughout pregnancy.
In summary, our study revealed a chronology of biologically-
diverse events over the course of pregnancy. Our findings were
enabled using seven high-throughput longitudinal biological assays of
the same patient cohort. The computational pipeline introduced in
this article can increase predictive power by combining datasets of
various sizes and modularities in a balanced way. We expect this pipe-
line to be applicable to a wide range of studies beyond the field of
pregnancy. Similarly, the dataset produced here provides a unique re-
source for future biological investigations. Particularly, this study can
be used as a resource to identify correlates of any other features from
one of the seven datasets that may be identified in future studies.
Finally, by characterizing the biological chronology of normal preg-
nancy, this study provides the conceptual and analytical framework to
analyze the complex interplays between various biological modalities
that govern preterm birth and other pregnancy-related pathologies.
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